Martin Babler - Chairman, President and CEO @ Alumis

Overview

Number of Current Board & Advisor Roles

CB Rank (Person)

Primary Job Title Chairman, President and CEO
Primary Organization
Alumis

Location San Francisco, California, United States
Regions San Francisco Bay Area, West Coast, Western US
Gender Male

LinkedIn View on LinkedIn

Martin Babler is the Chairman, President and CEO of Alumis. He previously worked at Principia Biopharma as a President and CEO. Martin Babler attended ETH Zurich.

Jobs

Number of Current Jobs

Number of Past Jobs

Martin Babler

is the

Chairman, President and CEO

Alumis

. Additionally,

Martin Babler

has had

past jobs including

CEO

Principia Biopharma

Alumis Chairman, President and CEOSep 2021

Organization Name	Title At Company	Start Date	End Date
Principia Biopharma	CEO	Apr 2011	Oct 2020
Talima Therapeutics	CEO	2008	2011
Genentech	Vice President of Immunology Sales	—	—
Genentech	Director of Cardiovascular Marketing	—	—
Eli Lilly	Sales Management, Marketing and Business Development	—	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

Martin Babler

holds

board and advisor roles including

Board Member

Neoleukin Therapeutics

Board Member

Prelude Therapeutics

, and

Chairman of the Board

Sardona Therapeutics

Neoleukin Therapeutics Board MemberSep 2021
Prelude Therapeutics Board MemberJul 2021
Sardona Therapeutics Chairman of the BoardMay 2021

Organization Name	Title At Company	Start Date	End Date
Principia Biopharma	Board Member	2011	2020
Infinity Pharmaceuticals	Board Member	—	—

Related Hubs

Hub Name	CB Rank (Hub)
California Biotechnology Companies	13,879
West Coast Female Founded Companies (Top 10K)	13,892
venBio Partners Portfolio Companies	83,855
Life Science Companies With More Than 100 Employees	18,718
California Public Companies	9,495
Life Science Companies With More Than $1M in Revenue	12,106
West Coast Public Companies With Less Than $10M in Revenue	58,593
United States Public Companies With Less Than $10M in Revenue	20,528
West Coast Biotechnology Companies	13,370
Medical Public Companies	12,487

Education

Martin Babler

studied at

ETH Zurich

ETH Zurich GraduatePharmacy